Canopy Growth (TSX:WEED) Expands Medical Cannabis Portfolio in Australia with New Formats and Formulations

September 8, 2026 — Leads & Copy — Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC), a global cannabis company, announced an expansion of its medical cannabis offerings in Australia. This broadening of its portfolio includes new product formats and formulations across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed, and Twd. brands.

The expansion introduces Canopy Growth’s first pastille format in Australia, under the Tweed and Spectrum brands. Products include Tweed Red 10, Tweed Blue 10:10, Spectrum Triple Balance 10:10:10, and Spectrum Dawn 1:10:5.

Additionally, the company is launching its first all-in-one (AIO) vape format in Australia. These include the 7 ACRES Fondant Live Resin AIO Vape 1 mL (Indica) and the Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL (Sativa).

Canopy Growth is also expanding its oil and softgel ranges. New oil formulations will now include CBG and CBN with Spectrum Flow and Spectrum Sunset. The softgel range is being expanded beyond isolate-based formulations with Spectrum White 50 and Spectrum Black 10.

The company also added two new SKUs to its Twd. value flower range.

“Expanding our product offering in established markets like Australia is central to our international medical strategy,” said Luc Mongeau, Chief Executive Officer, Canopy Growth. “These new formats and formulations reflect the continued strength of our global supply chain and our ability to evolve our existing portfolio while bringing a broader range of high-quality products to international markets.”

Andrew Bevan, President, Medical, Canopy Growth, noted the demand for increased choice in format and formulation from Australian prescribers and patients. “These launches give clinicians more options to tailor treatment approaches, while our new pastille and oil offerings reflect formulation work shaped by insights from our Canadian clinic and provider network.”

Canopy Growth is a global company focused on cannabis cultivation, quality, and innovation. Its brand portfolio includes Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL, and R’belle, along with Storz & Bickel. The company also operates as Canada’s leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo, and Canada House Clinics. Canopy Growth holds an unconsolidated interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.

Source: Canopy Growth Corporation

×

Welcome!

CannabisReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy

By Subscribing you will receive Daily Cannabis Story Leads via email 10:30 am ET Mon-Fri.